The anti-COVID-19 drug Paxlovid crosses biological barriers of the placenta and brain in rats [0.03%]
抗新冠肺炎药物帕克斯洛维德在大鼠体内穿越胎盘屏障和血脑屏障
Paxlovid (nirmatrelvir plus ritonavir) is an orally available drug for the treatment of COVID-19 disease. However, limited information remains on the biological barrier transfer of nirmatrelvir. In the present study, we investigated whether...